Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25669,901,0.74 [0.67-0.83],1.2094832416492262e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25703,146,0.70 [0.54-0.90],0.0053190290791771
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27286,156,0.76 [0.59-0.98],0.0372062878388885
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20395,504,0.73 [0.63-0.85],3.7550636778266304e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26503,79,0.67 [0.49-0.92],0.0139665048686825
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27747,109,0.71 [0.53-0.95],0.0207946554220069
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27706,68,0.63 [0.45-0.87],0.0058146931733192
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27455,393,0.67 [0.58-0.78],1.7267744776032958e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27207,145,0.60 [0.48-0.74],1.8732434643743875e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27314,252,0.69 [0.57-0.84],0.0001793890317067
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26165,824,0.65 [0.59-0.73],7.0190036566617655e-15
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28352,47,0.61 [0.42-0.89],0.0102511473111387
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma, any site",28354,47,0.61 [0.42-0.89],0.01026088190284
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27414,199,0.67 [0.54-0.82],0.0001231195026875
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27296,355,0.63 [0.55-0.73],1.2450387541417495e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27296,355,0.63 [0.55-0.73],1.2450387541417495e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27970,80,0.67 [0.49-0.92],0.0135200327850891
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28185,107,0.65 [0.49-0.85],0.0017119932884389
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27123,447,0.66 [0.58-0.76],9.0840524824401e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26838,339,0.68 [0.57-0.82],5.992690671755538e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26830,331,0.67 [0.56-0.81],2.8598335607347342e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26478,186,0.68 [0.52-0.90],0.0061926689538397
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26482,183,0.67 [0.51-0.88],0.0040689673440318
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24286,44,0.64 [0.42-0.98],0.0399656482320777
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Any mental disorder,24684,779,0.77 [0.68-0.88],9.872692285497056e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Smoking dependency,26412,69,0.67 [0.46-0.97],0.0363008095152582
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24301,396,0.68 [0.58-0.80],2.5382130761575216e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Depression,26696,343,0.68 [0.57-0.80],4.833161128886423e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Depression or dysthymia,24146,301,0.67 [0.56-0.80],1.1323858347669308e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24052,147,0.68 [0.53-0.87],0.0021025572642239
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Neurological diseases,25292,1460,0.71 [0.65-0.78],1.4928843572029465e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23594,162,0.52 [0.44-0.62],3.863123548482434e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28251,131,0.51 [0.42-0.61],1.100512628339954e-12
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27080,495,0.81 [0.69-0.95],0.0094140781349386
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Migraine,26688,103,0.69 [0.52-0.93],0.0132952122646504
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28077,93,0.68 [0.50-0.92],0.0126388382721598
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27957,40,0.64 [0.41-0.99],0.0432681630339646
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27302,621,0.81 [0.71-0.94],0.0041650489181814
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28231,85,0.58 [0.44-0.76],6.48694013336595e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Hemiplegia,28201,55,0.54 [0.39-0.74],0.0001116732559366
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other neurological diseases,28015,126,0.69 [0.53-0.90],0.0053759952637774
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22265,1990,0.88 [0.80-0.96],0.005221545183795
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28125,40,0.53 [0.37-0.75],0.0003514329251642
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23343,1327,0.81 [0.73-0.91],0.0001740095506472
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertension,23367,1351,0.82 [0.74-0.91],0.0003336750724042
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27914,63,0.66 [0.46-0.95],0.0259952992213269
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27915,64,0.66 [0.46-0.95],0.0256506260989192
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22076,60,0.67 [0.46-0.98],0.0396610981643878
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27739,85,0.65 [0.48-0.88],0.0055621510464525
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Varicose veins,27521,444,0.76 [0.65-0.88],0.0004410035043017
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,24087,1979,0.78 [0.72-0.85],5.906162666760363e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27834,216,0.74 [0.60-0.92],0.0069580123722168
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27832,214,0.74 [0.59-0.92],0.0061724592497679
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26043,889,0.69 [0.62-0.77],1.8221205970075828e-11
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Early onset COPD,27730,111,0.59 [0.45-0.77],9.498444941464432e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27730,111,0.59 [0.45-0.77],9.498444941464432e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27730,111,0.59 [0.45-0.77],9.498444941464432e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26653,806,0.72 [0.64-0.81],4.02115617311523e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Asthma,21774,806,0.70 [0.63-0.79],2.5347456630776142e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21628,806,0.70 [0.62-0.79],2.306857861137757e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21758,790,0.70 [0.62-0.78],1.522706768572636e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28260,58,0.60 [0.43-0.85],0.0038055661728924
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,27108,44,0.60 [0.40-0.89],0.0115215021007292
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",28323,44,0.61 [0.41-0.91],0.0154218470378665
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27101,37,0.60 [0.39-0.93],0.0225912712428116
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural effusion,27085,79,0.67 [0.48-0.92],0.0149601365993022
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,27191,185,0.76 [0.60-0.96],0.023883408354675
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,20111,5222,0.86 [0.81-0.91],5.213751719385169e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24422,1755,0.80 [0.73-0.87],3.571576392170861e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastric ulcer,22770,103,0.64 [0.49-0.85],0.0020926396065468
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28349,72,1.71 [1.01-2.90],0.0444986256460659
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Chronic gastritis,22768,101,0.59 [0.46-0.78],0.0001343284902239
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23313,646,0.80 [0.70-0.92],0.0016197940601308
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,23054,387,0.74 [0.62-0.87],0.0002292623083473
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22783,116,0.67 [0.51-0.88],0.0037541930535074
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Inguinal hernia,24858,403,1.81 [1.45-2.27],2.21084078245742e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25062,607,0.79 [0.69-0.91],0.0011973555211019
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27545,761,0.79 [0.69-0.89],0.0001203864472118
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,23403,1705,0.86 [0.79-0.94],0.0009190885045333
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27391,607,0.74 [0.65-0.85],8.069978228584008e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27386,602,0.74 [0.65-0.85],8.963333769743684e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21880,182,0.78 [0.61-0.99],0.0434117183063664
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21953,255,0.67 [0.56-0.80],9.188081444249474e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Constipation,27253,229,0.68 [0.56-0.82],9.019971900318824e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27184,534,0.70 [0.61-0.81],4.3643893269875046e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholelithiasis,27069,419,0.68 [0.59-0.79],5.429952005550772e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholecystitis,26730,80,0.61 [0.45-0.81],0.0006991420643493
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26697,47,0.64 [0.43-0.94],0.024855140903411
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27153,287,0.82 [0.67-1.00],0.0493866839016435
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26934,68,0.62 [0.45-0.85],0.0030841767521184
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Coeliac disease,26919,53,0.60 [0.42-0.85],0.0039164959607637
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25797,1510,0.91 [0.82-1.00],0.0454584910607431
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27328,544,0.83 [0.71-0.96],0.014711363419957
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22019,3561,0.78 [0.73-0.84],7.437374785189863e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23662,1883,0.86 [0.79-0.94],0.0008327676778542
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25978,1121,0.80 [0.72-0.89],3.306351689241189e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21897,118,0.52 [0.41-0.64],1.8461354823500411e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,22119,340,0.66 [0.55-0.78],9.58751370156119e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28110,112,0.53 [0.43-0.65],3.1505205784764806e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28127,100,0.51 [0.41-0.64],1.9407381779239022e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,22446,667,0.77 [0.67-0.88],0.0001496526703466
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",25080,667,0.78 [0.68-0.89],0.0003653410240397
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21825,46,2.11 [1.07-4.16],0.0319628149727872
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28052,45,2.52 [1.26-5.06],0.0093485605496512
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21930,151,0.64 [0.50-0.82],0.0003643249798181
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21905,126,0.69 [0.52-0.92],0.0106958689956394
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22008,229,0.63 [0.52-0.77],7.515987175626944e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21957,178,0.66 [0.53-0.82],0.0001813915475956
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21810,31,0.51 [0.34-0.76],0.0009442376807862
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22307,528,1.37 [1.14-1.65],0.0009634166532143
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22218,439,1.50 [1.22-1.85],0.0001488640932679
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,28050,154,0.61 [0.49-0.75],4.803939802211737e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27937,41,0.49 [0.36-0.67],9.51229578318388e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25612,222,0.74 [0.60-0.91],0.0053923639724613
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26309,919,0.75 [0.67-0.84],4.7222850706483097e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25528,138,0.64 [0.50-0.80],0.000162099036031
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26163,773,0.76 [0.67-0.86],6.9104982971715845e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25646,256,0.73 [0.60-0.89],0.0017063352805424
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25540,150,0.73 [0.57-0.95],0.0187128527516826
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25720,330,0.72 [0.61-0.86],0.000272779866673
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25093,236,0.73 [0.59-0.91],0.0048699088500798
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24913,56,0.60 [0.42-0.87],0.006175658641046
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24971,114,0.62 [0.48-0.80],0.0002996440208519
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25290,433,0.69 [0.59-0.80],1.363526036950188e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25003,146,0.69 [0.53-0.90],0.0054702864308595
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25083,226,0.74 [0.59-0.92],0.0064506030968228
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27043,100,0.69 [0.51-0.94],0.0175419286238256
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,24045,4459,0.63 [0.59-0.66],3.087912104752936e-54
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11534,420,0.81 [0.68-0.96],0.0143141947850134
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26903,893,0.76 [0.68-0.86],3.1252049801587768e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,26075,65,0.66 [0.47-0.93],0.0173548327886268
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26638,628,0.70 [0.62-0.79],1.3939107739016168e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,14303,2802,0.92 [0.84-1.00],0.0455756355145796
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,11800,299,0.79 [0.64-0.97],0.0259388617424519
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11616,115,0.72 [0.53-0.97],0.0316955717535889
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15564,230,0.75 [0.59-0.96],0.0208431803600612
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,15209,674,0.84 [0.71-0.99],0.0372591550061317
